Finch Therapeutics rallies $90m Series D
Somerville, Massachusetts-based Finch Therapeutics Group Inc, a clinical-stage microbiome drug development company, has secured $90 million in Series D financing.
Somerville, Massachusetts-based Finch Therapeutics Group Inc, a clinical-stage microbiome drug development company, has secured $90 million in Series D financing.
Copyright PEI Media
Not for publication, email or dissemination